Shandong Sito Bio-technology Future Growth
Future criteria checks 3/6
Shandong Sito Bio-technology is forecast to grow earnings and revenue by 54.7% and 12.4% per annum respectively. EPS is expected to grow by 54.5% per annum. Return on equity is forecast to be 3.7% in 3 years.
Key information
54.7%
Earnings growth rate
54.5%
EPS growth rate
| Pharmaceuticals earnings growth | 18.6% |
| Revenue growth rate | 12.4% |
| Future return on equity | 3.7% |
| Analyst coverage | Low |
| Last updated | 29 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 33% Share Price Surge Not Quite Adding Up
Sep 27
Why We're Not Concerned Yet About Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 26% Share Price Plunge
Jun 06There May Be Reason For Hope In Shandong Sito Bio-technology's (SZSE:300583) Disappointing Earnings
May 05Risks Still Elevated At These Prices As Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) Shares Dive 30%
Apr 16Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,669 | 84 | N/A | 301 | 1 |
| 12/31/2025 | 1,538 | 73 | N/A | 270 | 1 |
| 12/31/2024 | 1,404 | 57 | N/A | 646 | 1 |
| 6/30/2024 | 1,183 | -1 | 53 | 111 | N/A |
| 3/31/2024 | 1,189 | 33 | -169 | -82 | N/A |
| 12/31/2023 | 1,280 | 46 | -187 | -93 | N/A |
| 9/30/2023 | 1,302 | 62 | -243 | -151 | N/A |
| 6/30/2023 | 1,340 | 70 | -272 | -155 | N/A |
| 3/31/2023 | 1,393 | 45 | 39 | 147 | N/A |
| 1/1/2023 | 1,312 | 42 | 2 | 145 | N/A |
| 9/30/2022 | 1,253 | 46 | 161 | 415 | N/A |
| 6/30/2022 | 1,215 | 50 | 152 | 401 | N/A |
| 3/31/2022 | 1,184 | 54 | -42 | 295 | N/A |
| 1/1/2022 | 1,203 | 36 | -162 | 227 | N/A |
| 9/30/2021 | 1,070 | -99 | -306 | 34 | N/A |
| 6/30/2021 | 1,044 | -124 | -270 | 80 | N/A |
| 3/31/2021 | 963 | -161 | -108 | 189 | N/A |
| 12/31/2020 | 913 | -180 | 12 | 255 | N/A |
| 9/30/2020 | 904 | -77 | 68 | 232 | N/A |
| 6/30/2020 | 879 | -45 | 23 | 211 | N/A |
| 3/31/2020 | 901 | -1 | -79 | 138 | N/A |
| 12/31/2019 | 966 | 55 | -153 | 58 | N/A |
| 9/30/2019 | 992 | 110 | -309 | 29 | N/A |
| 6/30/2019 | 1,071 | 120 | -503 | -114 | N/A |
| 3/31/2019 | 1,099 | 129 | -695 | -320 | N/A |
| 12/31/2018 | 1,052 | 126 | -713 | -335 | N/A |
| 9/30/2018 | 1,129 | 146 | -558 | -266 | N/A |
| 6/30/2018 | 1,040 | 134 | -350 | -182 | N/A |
| 3/31/2018 | 923 | 117 | N/A | -48 | N/A |
| 12/31/2017 | 786 | 92 | N/A | 11 | N/A |
| 9/30/2017 | 690 | 74 | N/A | 15 | N/A |
| 6/30/2017 | 611 | 76 | N/A | 50 | N/A |
| 3/31/2017 | 624 | 99 | N/A | 80 | N/A |
| 12/31/2016 | 568 | 101 | N/A | 80 | N/A |
| 9/30/2016 | 562 | 115 | N/A | 64 | N/A |
| 12/31/2015 | 668 | 187 | N/A | 87 | N/A |
| 12/31/2014 | 521 | 166 | N/A | 174 | N/A |
| 12/31/2013 | 284 | 42 | N/A | 25 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300583 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Earnings vs Market: 300583 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 300583 is expected to become profitable in the next 3 years.
Revenue vs Market: 300583's revenue (12.4% per year) is forecast to grow slower than the CN market (13.5% per year).
High Growth Revenue: 300583's revenue (12.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300583's Return on Equity is forecast to be low in 3 years time (3.7%).